Featured Article
Machine learning and transcriptomics were combined to create a computational pipeline to predict patient response to cancer drugs, including resistance emergence, at single cell resolution.
Precision Oncology Today
Magazine
Beginning a New Era of Precision Alzheimer’s Therapeutics
Alzheimer’s is a disease associated with aging and impacts almost seven million people in the U.S. over the age of 65, with women and Black or Hispanic populations disproportionately affected by the condition. Finding an effective treatment for Alzheimer’s disease has proved to be a long and difficult quest.
5 Startups With Proteomics Potential Attracting Investor Cash
Investor appetite is growing for startups that can make proteomics faster, cheaper, and more informative for use in precision medicine. Here are five proteomics...
Trending on Inside Precision Medicine
Functional Precision Medicine Leads to Better Cancer Treatments
Researchers at Florida International University and First Ascent Biomedical have used an artificial intelligence (AI)-powered, functional precision medicine (FPM) platform to identify unique therapeutic treatment options for children with relapsed cancer diagnoses. IPM interviewed Azzam about her latest publication and the future of cancer research using FPM applications.
Urine-Based Prostate Cancer Test Promises to Reduce Unnecessary Biopsies
Researchers at the University of Michigan Rogel Cancer Center have announced the development of a novel urine-based test named MyProstateScore2.0 (MPS2), aiming to revolutionize the diagnosis of prostate cancer by identifying high-grade cancers that require immediate intervention.
Japanese Genomes Reveal Disease-Related Ancestry
Sequencing the genomes of thousands of people from Japan has shone new light on the origins of its population and traced disease-related genetic variants to extinct relatives of modern humans.
